SODIV ALSACE
Other
Active
3
1M
3
1
- Areas of investment
Summary
The fund was located in Europe if to be more exact in France. The main office of represented Corporate Investor is situated in the Mulhouse.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the SODIV ALSACE, startups are often financed by Sofinnova Partners, Idinvest Partners, Groupe Siparex. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Auriga Partners, Alsace Business Angels. In the next rounds fund is usually obtained by Seventure Partners, Michael J. Fox Foundation, Financiere De l'Echiquier.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2012. The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations.
We can highlight the next thriving fund investment areas, such as Commercial, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Domain Therapeutics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - France.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Investments by industry
- Biotechnology (3)
- Therapeutics (2)
- Health Care (2)
- Pharmaceutical (1)
- Health Diagnostics (1) Show 2 more
- Investments by region
-
- France (3)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Firalis | 30 Jun 2010 | Biotechnology, Commercial, Health Care, Industrial | Seed | 531K | France, Grand Est |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.